Post Wed Jun 07, 2023 3:37 pm

2023-Holtan et al-Transplant Cell Ther

"Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-Versus-Host Disease"
Shernan G Holtan, Andrea Hoeschen, Qing Cao, Celalettin Ustun, Brian C Betts, Najla El Jurdi, Joseph Maakaron, Armin Rashidi, Jeffrey S Miller, John E Wagner, Bruce R Blazar, Pamala A Jacobson, Angela Panoskaltsis-Mortari, Daniel J Weisdorf, Margaret L MacMillan
Transplant Cell Ther. 2023
https://doi.org/10.1016/j.jtct.2023.05.021

- no dataset accession given